Private Market View

Allbiotech

Aranguren, Spain · Founded 2024 · Privately Held (backing)

Last price · $/share
Implied valuation
Total raised
$20K
Last round

Key facts

  • It has raised $20K; the latest was Accelerator/Incubator ($20K) in Dec 2025.
  • Notable investors include Daniel Palacio, Ibai Meoki, Ignacio Hernández, Impulso Emprendedor, Jaime Urcola6 tracked in total.
  • Status: Privately Held (backing).
Free account
See the evidence behind this price
  • ·The complete investor list — 6 names
  • ·Watchlist + deal alerts for Allbiotech
  • ·The full record, as it builds
Create free account
No card required

Funding rounds

No rounds on record

No funding rounds for Allbiotech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

About Allbiotech

Manufacturer of precision fermentation equipment intended to enable food technology teams to cultivate and discover new biomolecules. The company provides fermentation hardware that supports controlled experimentation and efficient scaling in modern foodtech labs, enabling innovators in biotechnology to accelerate molecular development with reliable and cost-effective infrastructure.

Sector
Business Products and Services (B2B)
HQ
Aranguren, Spain
Founded
2024
Employees
7
Ownership
Privately Held (backing)
PA Mark — not yet priced

Allbiotech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.

Pro members can request priority coverage with a 48-hour turnaround.

Recorded secondary trades

No prints on record

No secondary trades in Allbiotech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.

Pro members can request priority coverage with a 48-hour turnaround.

Institutional fund marks

No fund marks yet

No SEC-registered fund has reported a fair-value mark on Allbiotech in its N-PORT filings yet. We sweep new filings monthly.

Pro members can request priority coverage with a 48-hour turnaround.